This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Ongoing Management of the HIV Patient in the Ambulatory Care Setting: Strategies for Achieving Long-term Viral Suppression

Ongoing Management of the HIV Patient in the Ambulatory Care Setting: Strategies for Achieving Long-term Viral Suppression


Slide Lecture Series

Time to Complete

1.50 hours


March 1, 2016


May 16, 2017
Add to Queue

Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM

Pharmacy Credits

Pharmacists may earn 1.50 CE Credits (0.15 CEUs) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website). Your certificate will save on and will not be included in your myCME CME History.

Accredited Provider

This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).

Commercial Supporter

Supported by an educational grant from Merck.

Program Description

The epidemic of human immunodeficiency virus (HIV) infection in the United States has changed dramatically in the last 30 years. The widespread use of antiretroviral therapy, in particular, can significantly suppress HIV replication, restore a patient’s immune function, and has resulted in a significant decline in HIV-related morbidity and mortality. As a result, patients on long-term therapy that maintain viral suppression can now manage their infection as a chronic illness and are likely to experience a near-normal life expectancy. Despite the remarkable advances in the management of patients living with HIV infection in the United States, challenges to successful HIV care remain.

Intended Audience

This continuing education activity was planned to meet the needs of pharmacists and physicians in a variety of practice settings, including large and small health systems, ambulatory care clinics, managed care organizations, and academia. The activity is particularly beneficial for pharmacists, physicians, clinical specialists, managers, leaders, and educators who are interested in HIV therapy.

Educational Objectives

At the conclusion of this application-based educational activity, participants should be able to:

  • Outline the diagnosis and management of acute HIV infection
  • Select patients who are appropriate candidates for switching antiretroviral regimens to improve convenience, safety or tolerability
  • Demonstrate the current approach to managing patients with HIV and hepatitis C co-infection

Conflict Of Interest Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.


Jason J. Schafer, Pharm.D., M.P.H., BCPS, AAHIVP (Activity Chair)
Associate Professor, Department of Pharmacy Practice
Jefferson College of Pharmacy
Clinical Pharmacy Specialist, HIV Ambulatory Care
Jefferson Infectious Diseases Associates
Thomas Jefferson University
Philadelphia, PA

Dr. Schafer declares he received a research grant from Merck.
Joseph A. DeSimone, Jr. M.D., FIDSA, AAHIVS
Professor of Medicine
Director, Infectious Diseases Fellowship Program
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA

Dr. DeSimone has no relevant financial relationships to disclose.

Planners' and Managers' Disclosures

The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.


In order to receive credit, participants must complete the post-test and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue